𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Germline mutations 657del5 of the NBS1 gene contribute significantly to the incidence of breast cancer in Central Poland

✍ Scribed by Jan Steffen; Dorota Nowakowska; Anna Niwińska; Dorota Czapczak; Anna Kluska; Magdalena Piątkowska; Alicja Wiśniewska; Zygmut Paszko


Publisher
John Wiley and Sons
Year
2006
Tongue
French
Weight
85 KB
Volume
119
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Recent studies have demonstrated that heterozygous carriers of the NBS1 657del5 mutation have an increased risk for familial and bilateral breast cancer, but similar studies in consecutive breast cancer patients were inconclusive. Here, in a study of 562 nonselected breast cancer patients from Central Poland, we found 11 (1.96%) 657del5 mutation carriers vs. 3.47 expected (OR 3.21, 95%CI: 1.36–7.61, p = 0.0107) and only 9 (1.6%) carriers of the 5382insC mutation of the BRCA1 gene, most frequently found among breast cancer patients in Poland. No carriers of R215W, another pathogenic mutation of the NBS1 gene, were found in the present study. All carriers of the 657del5 mutation had sporadic breast tumors while 5 of 9 5382insC carriers had a family history of breast/ovarian cancer or bilateral breast carcinoma. In the pooled group of patients from the present and our previous study, carried out also in patients from Central Poland, we obtained the following risk estimates (OR) for 657del5 carriers, as related to the age at breast cancer diagnosis: <40 years: 8.36; (95%CI: 2.57–27.27) p = 0.0003; <50 years: 4.27 (95%CI: 1.67–10.89) p = 0.003; ≥50 years: 2.40 (95%CI: 0.91–6.35) p = 0.1250; all ages: 3.13 (95% CI: 1.40–7.00) p = 0.0066. These findings demonstrate conclusively that NBS1 657del5 mutation carriers have a significantly, though moderately increased, age‐related risk of breast cancer, and imply that in populations with a high 657del5 carrier frequency this mutation may contribute substantially to the overall incidence of breast cancer, particularly in younger age groups. © 2006 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Germline 657del5 mutation in the NBS1 ge
✍ Bohdan Górski; Tadeusz Dębniak; Bartlomiej Masojć; Marek Mierzejewski; Krzysztof 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 60 KB

## Abstract In this report the proportion of consecutive and familial breast cancer cases harboring the 657del5 of exon 6 of the NBS1 gene was determined to assess whether it is associated with the increased risk of breast cancer development. The study consisted of 3 groups of patients: a series of

NBS1 657del5 mutation may contribute onl
✍ Konstantin G. Buslov; Aglaya G. Iyevleva; Elena V. Chekmariova; Evgeny N. Suspit 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 102 KB

## Abstract The gene for Nijmegen chromosomal breakage syndrome (__NBS1__) plays a role in a variety of processes protecting chromosomal stability. Recently, it was suggested in a Polish case‐control study that the founder hypomorphic mutation in __NBS1__, 657del5, which occurs in approximately 0.5

Increased risk of gastrointestinal lymph
✍ Jan Steffen; Galina Maneva; Lidia Popławska; Raymonda Varon; Olga Mioduszewska; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 78 KB

## Abstract The __NBS1__ gene mutation, 657del5, frequent in the Slavic populations of Central Europe, is found in most patients with Nijmegen breakage syndrome (NBS), a recessive autosomal disorder with a very high incidence of non‐Hodgkin lymphoma (NHL). We have previously described 2 heterozygou

Carrier frequency of mutation 657del5 in
✍ Krystyna H. Chrzanowska; Dorota Piekutowska-Abramczuk; Ewa Popowska; Małgorzata 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 94 KB

## Abstract Nijmegen breakage syndrome (NBS) is a human autosomal recessive disease characterized by genomic instability and enhanced cancer predisposition, in particular to lymphoma and leukemia. Recently, significantly higher frequencies of heterozygous carriers of the Slavic founder __NBS1__ mut